GB2050167A - X-ray contrast compositions - Google Patents

X-ray contrast compositions Download PDF

Info

Publication number
GB2050167A
GB2050167A GB8016355A GB8016355A GB2050167A GB 2050167 A GB2050167 A GB 2050167A GB 8016355 A GB8016355 A GB 8016355A GB 8016355 A GB8016355 A GB 8016355A GB 2050167 A GB2050167 A GB 2050167A
Authority
GB
United Kingdom
Prior art keywords
composition
acid
ray contrast
ionic
nonionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8016355A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of GB2050167A publication Critical patent/GB2050167A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB8016355A 1979-05-21 1980-05-16 X-ray contrast compositions Withdrawn GB2050167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4057079A 1979-05-21 1979-05-21

Publications (1)

Publication Number Publication Date
GB2050167A true GB2050167A (en) 1981-01-07

Family

ID=21911706

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8016355A Withdrawn GB2050167A (en) 1979-05-21 1980-05-16 X-ray contrast compositions

Country Status (7)

Country Link
JP (1) JPS55154920A (fr)
AU (1) AU5856480A (fr)
BE (1) BE883383A (fr)
DE (1) DE3018515A1 (fr)
FR (1) FR2457104A1 (fr)
GB (1) GB2050167A (fr)
NL (1) NL8002388A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014478A1 (fr) * 1992-12-24 1994-07-07 Bracco S.P.A. Compositions aqueuses injectables utilisees pour le radiodiagnostic contenant des composes aromatiques iodes servant de substances de contraste aux rayons x

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19627309C2 (de) * 1996-06-27 1999-07-29 Schering Ag Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2613172A (en) * 1949-08-10 1952-10-07 American Cystoscope Makers Inc X-ray contrast compositions
US2921884A (en) * 1957-09-30 1960-01-19 Sterling Drug Inc Pharmaceutical compositions
AT332534B (de) * 1972-04-12 1976-10-11 Beecham Group Ltd Rontgenkontrastmittel
CH608189A5 (fr) * 1974-12-13 1978-12-29 Savac Ag

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014478A1 (fr) * 1992-12-24 1994-07-07 Bracco S.P.A. Compositions aqueuses injectables utilisees pour le radiodiagnostic contenant des composes aromatiques iodes servant de substances de contraste aux rayons x
US5695742A (en) * 1992-12-24 1997-12-09 Dibra S.P.A. Aqueous injectable formulations useful for radiodiagnosis comprising iodinated aromatic compounds used as X-ray contrast media

Also Published As

Publication number Publication date
AU5856480A (en) 1980-11-27
FR2457104A1 (fr) 1980-12-19
DE3018515A1 (de) 1980-12-04
JPS55154920A (en) 1980-12-02
BE883383A (fr) 1980-11-20
NL8002388A (nl) 1980-11-25

Similar Documents

Publication Publication Date Title
Almen Contrast agent design: some aspects on the synthesis of water soluble contrast agents of low osmolality
EP0675738B1 (fr) Compositions aqueuses injectables utilisees pour le radiodiagnostic contenant des composes aromatiques iodes servant de substances de contraste aux rayons x
US5866100A (en) Compositions for imaging of the gastrointestinal tract
EP1725268B1 (fr) Formulations de milieux de contraste de rayons x comprenant un melange de monomere et dimere iode
SK278621B6 (en) The contrasting agent
US5447711A (en) Contrast media
US5366722A (en) Contrast media comprising a non-ionic contrast agent and sodium ions
GB2050167A (en) X-ray contrast compositions
Slätis et al. Hyperosmolality of the cerebrospinal fluid as a cause of adhesive arachnoiditis in lumbar myelography
Nyman et al. Effect of Contrast Media on Femoral Blood Flow: Comparison between non-ionic and ionic monomelic and monoacidic dimeric contrast media in the dog
US2677645A (en) Dextran roentgenographic preparation
WO2000037115A1 (fr) Milieu de contraste soluble dans l'eau et destine a un examen radiologique
NAKAMURA et al. Effects of ionic and nonionic contrast media on cardiohemodynamics and quality of radiographic image during canine angiography
Doyon et al. Comparative trial of Hexabrix (320 mg iodine/ml), iohexol (300 mg iodine/ml) and Iopamiron (300 mg iodine/ml) in cerebral and spinal angiography: a preliminary report
Björk et al. A new contrast medium for hysterosalpingo-pelvigraphy
US3855405A (en) Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof
Van Voorthuisen Experiences with Isopaque B in Angiocardiography and Abdominal Angiography
Dobben et al. Experimentelle Untersuchungen mit einem Fluorcarbon-Kontrastmittel für den Subarachnoidealraum
SOVAK Iodinated Contrast Media: State of the Art and the Thorny Path toward Reduction of Osmolality

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)